PET Scan Imaging in Assessing Response in Patients With Esophageal Cancer Receiving Combination Chemotherapy
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Karyn A. Goodman, MD
Memorial Sloan Kettering Cancer Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
68 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Camino Medical Group - Treatment Center
Mountain View, California, United States
- Palo Alto Medical Foundation
Palo Alto, California, United States
- Ucsf Helen Diller Family Comprehensive Cancer Center
San Francisco, California, United States
- Yale Cancer Center
New Haven, Connecticut, United States
- Tunnell Cancer Center at Beebe Medical Center
Lewes, Delaware, United States
- Ccop - Christiana Care Health Services
Newark, Delaware, United States
- Lombardi Comprehensive Cancer Center at Georgetown University Medical Center
Washington D.C., District of Columbia, United States
- Kapiolani Medical Center for Women and Children
Honolulu, Hawaii, United States
- Kuakini Medical Center
Honolulu, Hawaii, United States
- Oncare Hawaii, Incorporated - Kuakini
Honolulu, Hawaii, United States
- Oncare Hawaii, Incorporated - Lusitana
Honolulu, Hawaii, United States
- Queen'S Cancer Institute at Queen'S Medical Center
Honolulu, Hawaii, United States
- Straub Clinic and Hospital, Incorporated
Honolulu, Hawaii, United States
- Castle Medical Center
Kailua, Hawaii, United States
- Kauai Medical Clinic
Lihue, Hawaii, United States
- Kapiolani Medical Center at Pali Momi
‘Aiea, Hawaii, United States
- Oncare Hawaii, Incorporated - Pali Momi
‘Aiea, Hawaii, United States
- John H. Stroger, Jr. Hospital of Cook County
Chicago, Illinois, United States
- Robert H. Lurie Comprehensive Cancer Center at Northwestern University
Chicago, Illinois, United States
- University of Chicago Cancer Research Center
Chicago, Illinois, United States
- Ccop - Illinois Oncology Research Association
Peoria, Illinois, United States
- Oncology Hematology Associates of Central Illinois, Pc - Peoria
Peoria, Illinois, United States
- Ccop - Carle Cancer Center
Urbana, Illinois, United States
- Mcfarland Clinic, Pc
Ames, Iowa, United States
- Siouxland Hematology-Oncology Associates, Llp
Sioux City, Iowa, United States
- Union Hospital of Cecil County
Elkton, Maryland, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Saint Joseph Mercy Cancer Center
Ann Arbor, Michigan, United States
- Regions Hospital Cancer Care Center
Saint Paul, Minnesota, United States
- United Hospital
Saint Paul, Minnesota, United States
- University of Mississippi Cancer Clinic
Jackson, Mississippi, United States
- Regional Cancer Center at Singing River Hospital
Pascagoula, Mississippi, United States
- Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis
St Louis, Missouri, United States
- Billings Clinic - Downtown
Billings, Montana, United States
- Methodist Estabrook Cancer Center
Omaha, Nebraska, United States
- Cancer Institute of New Jersey at Umdnj - Robert Wood Johnson Medical School
New Brunswick, New Jersey, United States
- Cancer Institute of New Jersey at Cooper - Voorhees
Voorhees Township, New Jersey, United States
- Memorial Sloan-Kettering Cancer Center
New York, New York, United States
- Mount Sinai Medical Center
New York, New York, United States
- Nyu Cancer Institute at New York University Medical Center
New York, New York, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2011
- Primary completion
- 30 Nov 2015
- Completion
- 1 Apr 2023
- Last update posted
- 13 Apr 2023
- Registered enrollment
- 257
- Registry id
- NCT01333033
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.